The clinical-stage biotech could see its shares plummet should there be any clinical setback.

In a recent report, remote-work site FlexJobs noted that work-from-home job postings recently increased by 3%, indicating ...

Biotech companies provide the medical innovations and technological breakthroughs that improve healthcare and can achieve ...

Over the past few years, Axsome Therapeutics has made slow and steady clinical and regulatory progress. The company's lineup ...

That morning, Vera announced that its biologics license application (BLA) for its atacicept was accepted for priority review ...

Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year.

JPMorgan has released its latest U.S. Analyst Focus List, highlighting top healthcare investment ideas across growth, income, value, and short strategies. The healthcare sector continues to ...

Most Americans likely will not benefit immediately from efforts to lower prescription prices. Administration officials expect ...

While Novartis secured the biggest deal of the fourth quarter, a handful of riveting tales emerged from the bottom of the M&A ...

Most biotech firms will be forced to reevaluate foreign relationships and re-route supply chains, or hope for a federal ...

Participants in the program via the Indiana Life Sciences Association can receive significant discounts—up to 75%—off list ...

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to ...